Old Web
English
Sign In
Acemap
>
authorDetail
>
Samuel Hong
Samuel Hong
University of Texas MD Anderson Cancer Center
Medicine
Cancer research
Antibody
Molecular biology
Immunology
4
Papers
28
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Activating KRAS, NRAS, and BRAF mutants enhance proteasome capacity and reduce endoplasmic reticulum stress in multiple myeloma.
2020
Proceedings of the National Academy of Sciences of the United States of America
Fazal Shirazi
Richard J. Jones
Ram Kumar Singh
Jianxuan Zou
Isere Kuiatse
Zuzana Berkova
Hua Wang
Hans C. Lee
Samuel Hong
Larry Dick
Nibedita Chattopadhyay
Robert Z. Orlowski
Show All
Source
Cite
Save
Citations (11)
HDP-101, a Novel BCMA-targeted Antibody Conjugated to α-Amanitin, is Active against Myeloma with Preferential Efficacy against Pre-clinical Models of Deletion 17p
2019
Clinical Lymphoma, Myeloma & Leukemia
Ram Kumar Singh
Richard Julian Jones
Fazal Shirazi
Samuel Hong
Hua Wang
Jie Wan
Isere Kuitase
Andreas Pahl
Robert Z. Orlowski
Show All
Source
Cite
Save
Citations (6)
HDP101, a Novel B-Cell Maturation Antigen (BCMA)-Targeted Antibody Conjugated to α-Amanitin, Is Active Against Myeloma with Preferential Efficacy Against Pre-Clinical Models of Deletion 17p
2018
Blood
Ram Kumar Singh
Richard J. Jones
Samuel Hong
Fazal Shirazi
Hua Wang
Isere Kuiatse
Andreas Pahl
Robert Z. Orlowski
Show All
Source
Cite
Save
Citations (10)
Activating KRAS, NRAS, and BRAF Mutants Enhance Proteasome Capacity and Reduce Endoplasmic Reticulum Stress in Multiple Myeloma, Thereby Promoting Plasma Cell Survival and Proteasome Inhibitor Resistance
2018
Blood
Fazal Shirazi
Richard J. Jones
Isere Kuiatse
Zuzana Berkova
Hua Wang
Hans C. Lee
Samuel Hong
Ram Kumar Singh
Lawrence Robert Dick
Nibedita Chattopadhyay
Robert Z. Orlowski
Show All
Source
Cite
Save
Citations (1)
1